Protein-Based Drugs: Design and Application
This special issue belongs to the section "Biochemical Engineering".
Special Issue Information
Dear Colleagues,
Protein-based drugs have become an important class of modern therapeutics, including monoclonal antibodies, recombinant proteins, enzymes, cytokines, and sub-unite protein vaccines. Recent advances in structural biology, protein engineering, computational modeling, and artificial intelligence have greatly expanded the possibilities for designing proteins with improved specificity, affinity, stability, and therapeutic efficacy. However, translating these advances into effective and clinically applicable therapeutics still requires better strategies for protein discovery, rational design, functional optimization, characterization, and development.
This Special Issue on “Protein-Based Drugs: Design and Application” will focus on recent advances in the design, engineering, characterization, development, and therapeutic application of protein-based drugs. Contributions combining experimental and computational approaches are particularly welcome.
Topics of interest include, but are not limited to:
- Rational and structure-based protein drug design
- Antibody discovery and engineering
- AI-assisted protein design and optimization
- Protein stability, affinity, specificity, and developability
- Structural and biophysical characterization of protein therapeutics
- Novel protein therapeutic modalities and delivery strategies
- Manufacturing, formulation, and translational development
- Applications of protein-based drugs in infectious diseases, cancer, and other major diseases
Dr. Zhiteng Li
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the Special Issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Bioengineering is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- protein-based drugs
- protein engineering
- rational protein design
- structural biology
- artificial intelligence
- computational modeling
- therapeutic proteins
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

